Volitinib
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Volitinib, covering 2016-04-08 to 2025-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Volitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors [Phase 1]